谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

116P Interim analysis of 300 patients with HER2+/HR+ early breast cancer enrolled in the multi-national, prospective, observational ELEANOR NIS treated with extended adjuvant neratinib in clinical routine

R. Bartsch,N. Harbeck,D. Wrobel,D. Guth,M. Zaiss,J. Terhaag,M-O. Zahn,A. Distelrath, K.R. Apel, N. Deuerling,C. Vannier, D.I. Lüftner,U. Breitenstein

ESMO Open（2024）

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要